Phosphatidylinositol 3-Kinase Inhibitors Block Aortic Smooth Muscle Cell Proliferation in Mid-Late G1 Phase: Effect on Cyclin-Dependent Kinase 2 and the Inhibitory Protein p27KIP1
- 27 March 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 244 (3), 630-636
- https://doi.org/10.1006/bbrc.1997.7885
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2FNature, 1997
- Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.JCI Insight, 1997
- Phosphatidylinositol 3-kinase related kinasesCurrent Opinion in Immunology, 1996
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.JCI Insight, 1995
- Novel functions of phosphatidylinositol 3-kinase in terminally differentiated cellsCellular Signalling, 1995
- Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinaseTrends in Biochemical Sciences, 1995
- Molecular and cellular concepts in atherosclerosisPharmacology & Therapeutics, 1994
- G1 phase progression: Cycling on cueCell, 1994
- Structure, regulation and function of phosphoinositide 3-kinasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- Synthesis of sulfated proteoglycans throughout the cell cycle in smooth muscle cells from pig aortaExperimental Cell Research, 1986